Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family
of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart …

Management of gastroesophageal reflux disease (GERD) commonly starts with an empiric
trial of proton pump inhibitor (PPI) therapy and complementary lifestyle measures, for …

Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD)
do not respond completely to proton pump inhibitor (PPI) therapy. The term “refractory …

Antireflux surgery anatomically restores the antireflux barrier and is a therapeutic option for
proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease or PPI intolerance …

Abstract Background The LINX® magnetic sphincter augmentation system (MSA) is a
surgical technique with short-term evidence demonstrating efficacy in the treatment of …

Background and Aims GERD patients frequently complain of regurgitation of gastric
contents. Medical therapy with proton-pump inhibitors (PPIs) is frequently ineffective in …

Background: As previously reported, the magnetic sphincter augmentation device (MSAD)
preserves gastric anatomy and results in less severe side effects than traditional antireflux …

Introduction Magnetic sphincter augmentation (MSA) of the lower esophageal sphincter
restores the antireflux barrier in patients with hiatal hernias≤ 3 cm. We performed a …

Abstract Background Laparoscopic Nissen and Toupet fundoplication (LF) are currently
considered gold-standard surgical treatment for Gastroesophageal Reflux Disease (GERD) …